Abstract
Endocrine tumors of the gastrointestinal tract are a heterogeneous population of neoplasms differing from each other by their secretory and functional properties, pathogenetic mechanisms, related clinical syndromes, pathological associations, and prognosis. Although such heterogeneity and the relative rarity of these tumors hamper systematic investigations, significant advances in several aspects of tumor pathology have been achieved in recent years. This article focuses on the genetic background of tumor development with emphasis on the role of the MEN-1 oncosuppressor gene in either MEN-1-associated or sporadic endocrine tumors, on the identification and pathologic relevance of tumor-produced growth factors, and on the mechanism of induction of gastrin-dependent ECL cell carcinoids of the stomach.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
